ArticleClinical ophthalmology (Auckland, N.Z.)2018

Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study.

Kanji Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.